0      0


172 - Advanced Practice - You're Taking What? Medication Dosing in CKD and ESRD


‐ Apr 16, 2018 4:15pm


Credits: None available.

Contact hours available until 4/18/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosures:
• Cynthia Smith – Speakers Bureau, Abbvie; Speakers Bureau, Relypsa/Vifor; Speakers Bureau, Sanofi-Genzyme; Consultant, Abbvie Renal Advisory Board; Consultant, Sanofi-Genzyme Advanced Practice Nurses Advisory Board for Lysosomal Storage Disorders; Contributor, Medical-Surgical Nursing: Assessment and Management of Clinical Problems (Elsevier); received honoraria for podcast on Veltassa for use by the British Journal of Cardiology
• John Wigneswaran – Employee, DaVita; Employee, Nephroceuticals; Stock, DaVita; Stock, Nephroceuticals; Advisory Board, Inmoji

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcome:
Advanced practice nephrology nurses will describe an increased comfort level with dosage and considerations for patients with CKD and ESRD.


Speaker(s):

Tags:

apn pharm

Credits Available


You must be logged in and own this session in order to post comments.